View Post

Enrollment Complete in Phase 2 Trial of NeuVax-Herceptin for HER2-Positive, High-Risk Breast Cancer

In Clinical Trials by Barbara Jacoby

By: Alice Melão From: breastcancer-news.com The investigator-sponsored trial studying a combination of NeuVax (nelipepimut-S, NPS) and Herceptin (trastuzumab) as a maintenance treatment for HER2-positive breast cancer at high risk of recurrence has completed patient enrollment, Sellas Life Sciences, NeuVax’s developer, has announced. Top-line data from the trial is expected by the end of 2019. “The completion of enrollment of this Phase 2 clinical …

View Post

New Clinical Trial for Triple-Negative Breast Cancer at Sylvester Comprehensive Cancer Center

In Clinical Trials by Barbara Jacoby

Vaccine Designed to Prevent Recurrence Panic washed over Jackie Barrett when she first received her breast cancer diagnosis. “My eyes went dark. I couldn’t hear anything. It was like a train was coming at me,” she says. Jackie’s oncologist explained that her type of breast cancer is called triple-negative because it does not have receptors for estrogen, progesterone or the …

View Post

Have scientists found an anti-cancer vaccine?

In In The News by Barbara Jacoby

By: Ana Sandoiu From: medicalnewstoday.com Researchers from Stanford University used stem cells to create a vaccine that has proven effective against breast, lung, and skin cancer in mice. To produce the vaccine, the scientists turned to induced pluripotent stem cells (iPSCs), or stem cells that are generated from adult cells. Over a decade ago, Japanese-based scientists showed for the first …

View Post

FORMER ONCOLOGY BIOTECH CEO BATTLING TERMINAL CANCER GIVES UNIQUE INSIGHT IN NEW GRIPPING MEMOIR

In In The News by Barbara Jacoby

A Walk With Purpose: Memoir of a Bioentrepreneur By Michael D. Becker “Nothing is as sobering or life-changing as those dreaded words, ‘you have cancer.’ This is a story of a husband, father and bright entrepreneur whose very private struggle with a preventable cancer has been made public with amazing clarity, insight and can’t put-the- book-down humanity.”  -James L Gulley, …

View Post

Seattle lab’s vaccine could be cancer breakthrough

In In The News by Barbara Jacoby

By: John Knicely From: myajc.com Etubics Corporation, a biopharmaceutical company in Seattle’s Lower Queen Anne neighborhood, is moving forward after a major breakthrough in treating cancer patients. A new type of treatment more than doubled the life span of some cancer patients. Now, the lab has the backing of the National Cancer Institute in testing its immunotherapy for cancer patients. …

View Post

Cuba’s lung cancer vaccine is heading to the US for clinical trials

In In The News by Barbara Jacoby

By Andrew O’Reilly From: foxnews.com Since Fidel Castro took power in Cuba in 1959, the communist nation has been known for, among other things, its “medical diplomacy” – sending doctors and medicine to far flung parts of the globe in order to foster goodwill and gain allies on the world stage. But because of the long-standing embargo against Cuba, one …

View Post

Israeli Company’s Vaccine Blocks 90% of Cancer Types

In In The News by Barbara Jacoby

By Arutz Sheva Staff From: israelnationalnews.com Vaxil BioTherapeutics’s ImMucin trains immune system to fight cancer cells and prevent the disease’s return for early stages and remission. An Israeli biotech company is developing a vaccine for cancer that it says can help prevent the return of the lethal disease for 90% of the different types of cancer. Vaxil BioTherapeutics based in …